Breast cancer drugs take hidden toll on hearts, Swedish study shows

A large Swedish study tracking breast cancer patients over years found that cancer therapies cause serious heart damage far more often than previously recognized in real-world care. The finding could reshape how oncologists monitor patients and forces pharmaceutical companies and health systems to reckon with long-term treatment costs beyond cancer survival.

Originaltitel: Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study